Trial of Long-term Therapeutic Hypothermia for Poor-grade Aneurysmal Subarachnoid Hemorrhage

NCT03442608 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-02-26

No results posted yet for this study

Summary

This study is a prospective, multi-centre, randomized,controlled trial to compare the efficacy of long-term mild hypothermia with normothermic intensive management in patients with poor-grade aneurysmal subarachnoid hemorrhage.

The primary hypothesis is that the induction of mild hypothermia (maintained at 32-35℃) for at least 5 days would improve the outcome of patients at six months post hemorrhage compared with normothermia.

Conditions

  • Hypothermia
  • Aneurysmal Subarachnoid Hemorrhage

Interventions

PROCEDURE

Zoll 2000 and/or CureWrap 3500 cooling system

Device(Zoll 2000 and/or CureWrap 3500 cooling system),lasting 5 to 7 days, the core temperature will be controlled in 33-35 degree.

Sponsors & Collaborators

  • First Affiliated Hospital of Fujian Medical University

    collaborator OTHER
  • Central South University

    collaborator OTHER
  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    collaborator OTHER
  • Tang-Du Hospital

    collaborator OTHER
  • First Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • The First Hospital of Jilin University

    collaborator OTHER
  • The First Affiliated Hospital of Dalian Medical University

    collaborator OTHER
  • Shanxi Cardiovascular Hospital

    collaborator OTHER
  • Qilu Hospital of Shandong University

    collaborator OTHER
  • First Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER
  • Shandong Provincial Hospital

    collaborator OTHER_GOV
  • Yantai Yuhuangding Hospital

    collaborator OTHER
  • Beijing Tiantan Hospital

    collaborator OTHER
  • Xuanwu Hospital, Beijing

    lead OTHER

Principal Investigators

  • Ning Wang, MD,PhD · Xuanwu Hospital,Capital Medical University, Beijing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2020-12-31
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03442608 on ClinicalTrials.gov